Literature DB >> 22528464

An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.

Xiao-ming He1, Zhen-xin Zhang, Jun-Wu Zhang, Yong-tao Zhou, Cheng-bin Wu, Mou-ni Tang, Zhen Hong.   

Abstract

Excess cholesterol is removed from the brain via hydroxylation mediated by cholesterol 24S-hydroxylase (CYP46), which is a mechanism of maintaining cholesterol homeostasis in the brain. The CYP46A1 gene has been suggested as a genetic risk factor for sporadic late-onset Alzheimer's disease (AD). In this report, we analyzed an intronic CYP46A1 single nucleotide polymorphism (SNP) in 508 sporadic AD patients and 549 controls in a Chinese Han population. Our results indicated that the distribution of CYP46A1 SNP rs754203 genotypes was significantly different in AD patients compared to controls (χ(2) = 6.59, P = 0.037). The frequency of at least one of CYP46A1 T allele (C/T or T/T) was higher in AD patients compared to controls (χ(2) = 6.58, P = 0.01). The age- and sex-adjusted odds ratio for the risk of AD in carriers of CYP46A1 T allele (C/T + T/T) was 1.69 (95 % confidence interval, 1.12-2.56). We conclude that this intronic polymorphism in CYP46A1 gene is associated with AD in a Chinese Han population, and the CYP46A1 T allele might be a risk factor for AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528464     DOI: 10.1007/s12031-012-9778-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.

Authors:  Amro Kabbara; Nathalie Payet; Dominique Cottel; Bernard Frigard; Philippe Amouyel; Jean-Charles Lambert
Journal:  Neurosci Lett       Date:  2004-06-10       Impact factor: 3.046

Review 2.  Genetic association of CYP46 and risk for Alzheimer's disease.

Authors:  Onofre Combarros; Jon Infante; Javier Llorca; José Berciano
Journal:  Dement Geriatr Cogn Disord       Date:  2004-07-29       Impact factor: 2.959

3.  Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients.

Authors:  Y Li; L W Chu; Y Q Chen; B M Y Cheung; R Y H Leung; P Y Yik; K M Ng; W Mak; D Y Jin; P St George-Hyslop; Y Q Song
Journal:  Dement Geriatr Cogn Disord       Date:  2006-09-08       Impact factor: 2.959

4.  Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.

Authors:  S Helisalmi; S Vepsäläinen; A M Koivisto; A Mannermaa; S Iivonen; M Hiltunen; V Kiviniemi; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

5.  Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.

Authors:  Gloria Lena Vega; Myron F Weiner; Anne M Lipton; Klaus Von Bergmann; Dieter Lutjohann; Carol Moore; Doris Svetlik
Journal:  Arch Neurol       Date:  2003-04

6.  Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

Authors:  A Papassotiropoulos; D Lütjohann; M Bagli; S Locatelli; F Jessen; M L Rao; W Maier; I Björkhem; K von Bergmann; R Heun
Journal:  Neuroreport       Date:  2000-06-26       Impact factor: 1.837

7.  cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.

Authors:  E G Lund; J M Guileyardo; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

8.  Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.

Authors:  Heike Kölsch; D Lütjohann; M Ludwig; A Schulte; U Ptok; F Jessen; K von Bergmann; M L Rao; W Maier; R Heun
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

9.  CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.

Authors:  Heike Kölsch; Dieter Lütjohann; Frank Jessen; Julius Popp; Frank Hentschel; Peter Kelemen; Sandra Schmitz; Wolfgang Maier; Reinhard Heun
Journal:  Eur Psychiatry       Date:  2009-03-16       Impact factor: 5.361

10.  Brain cholesterol, statins and Alzheimer's Disease.

Authors:  C Kirsch; G P Eckert; A R Koudinov; W E Müller
Journal:  Pharmacopsychiatry       Date:  2003-09       Impact factor: 5.788

View more
  6 in total

1.  CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.

Authors:  Ling Li; Fan Zeng; Yu-Hui Liu; Hui-Yun Li; Shu-Yang Dong; Ze-Yan Peng; Yan-Jiang Wang; Hua-Dong Zhou
Journal:  Mol Neurobiol       Date:  2018-03-07       Impact factor: 5.590

Review 2.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

3.  Association of G/C (rs638405) Polymorphism in β-secretase Gene with Alzheimer's Disease.

Authors:  Mostafa Chashmpoosh; Hossein Babaahmadi; Rouhollah Mousavidehmordi; Bita Shalbafan; Asma Mohammadi; Alireza Kheirollah
Journal:  Avicenna J Med Biotechnol       Date:  2018 Oct-Dec

4.  LincRNA Plays a Role in the Effect of CYP46A1 Polymorphism in Alzheimer's Disease - Related Pathology.

Authors:  Yang Chen; Hui-Yun Li; Fan Zeng; Le Chen; Fa-Ying Zhou; Ze-Yan Peng; Hai Yang; Hua-Dong Zhou; Yan-Jiang Wang; Ling Li
Journal:  Front Aging Neurosci       Date:  2020-01-21       Impact factor: 5.750

Review 5.  Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol.

Authors:  Mingan Wu; Yingying Zhai; Xiaoyi Liang; Weichun Chen; Ruiyi Lin; Linlin Ma; Yi Huang; Di Zhao; Yong Liang; Wei Zhao; Jiansong Fang; Shuhuan Fang; Yunbo Chen; Qi Wang; Weirong Li
Journal:  Front Neurosci       Date:  2022-04-07       Impact factor: 5.152

6.  Increased Plasma Level of 24S-Hydroxycholesterol and Polymorphism of CYP46A1 SNP (rs754203) Are Associated With Mild Cognitive Impairment in Patients With Type 2 Diabetes.

Authors:  Jijing Shi; Jianhong Jia; Sai Tian; Haoqiang Zhang; Ke An; Wenwen Zhu; Wuyou Cao; Yang Yuan; Shaohua Wang
Journal:  Front Aging Neurosci       Date:  2021-05-13       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.